INNB Experimental Neuro-Oncology and Gene Therapy


Neuro-oncol 2006; 8(2): 96-108; first published on March 2, 2006 as DOI: 10.1215/15228517-2005-006


Supplemental Items

Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1

Tiziana Piepoli, Cemile Jakupoglu, Wenli Gu, Elena Lualdi, Blanca Suarez-Merino, Pietro L. Poliani, Maria Grazia Cattaneo, Barbara Ortino, Dorota Goplen, Jian Wang, Rosa Mola, Francesca Inverardi, Carolina Frassoni, Rolf Bjerkvig, Ortrud Steinlein, Lucia M. Vicentini, Oliver Brüstle and Gaetano Finocchiaro

 


Figures

Figure 1-S. LGI1 in GL261 cells, human organs and primary glioblastomas.
Figure 2-S. ELISA determination of MMP3 release in the culture medium of U87-mock and U87-LGI1 cells.
Figure 3-S. In vitro expression of LGI1 and TIMP-3 in U87 cells.
Figure 4-S


Tables

Table 1-S. Genes down-regulated in the two micro-array experiments comparing U87-mock and U87-LGI1 cells (Table 1A-S).
    
Genes up-regulated in the two micro-array experiments comparing U87-mock and U87-LGI1 cells (Table 1B-S).
Table 2-S.





 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP